Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

NCT03010761 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

90

Enrollment

OTHER

Sponsor class

Stopped all participants finished the trial

Conditions

Addiction

Interventions

DRUG: escitalopram
DRUG: Moclobemide
DRUG: Placebo - Cap

Sponsor

China Medical University Hospital